Rectal Cancer Clinical Trials in Guangzhou, Guangdong
48 recruitingGuangzhou, Guangdong, China
Showing 1–20 of 48 trials
Recruiting
Not Applicable
Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University47 enrolled1 locationNCT04643041
Recruiting
Phase 3
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
Rectal Cancer
Yanhong Deng582 enrolled1 locationNCT04215731
Recruiting
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
Lung Cancer (Diagnosis)CRC (Colorectal Cancer)
Nanfang Hospital, Southern Medical University1,000 enrolled1 locationNCT07239063
Recruiting
Phase 3
mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang166 enrolled1 locationNCT06791512
Recruiting
Phase 2
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Sun Yat-sen University198 enrolled3 locationsNCT05959356
Recruiting
Phase 2
Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
BRAF V600 Colorectal Cancer
Sun Yat-sen University20 enrolled1 locationNCT07150247
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Phase 1Phase 2
TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
RAS/BRAF Wild Type Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.72 enrolled27 locationsNCT07044908
Recruiting
Phase 1Phase 2
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Colorectal Cancer Metastatic
Sun Yat-sen University64 enrolled1 locationNCT07012954
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd.214 enrolled13 locationsNCT06839105
Recruiting
Phase 2
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Colorectal Cancer Metastatic
Sun Yat-sen University194 enrolled1 locationNCT05727163
Recruiting
Phase 2
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
Rectal CancerRadiotherapyNeoadjuvant Therapies+1 more
Sixth Affiliated Hospital, Sun Yat-sen University80 enrolled1 locationNCT06923345
Recruiting
Phase 2
Neoadjuvant Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Colorectal Cancer (CRC)PD-1 InhibitorNeoadjuvant Immunotherapy+2 more
Sun Yat-sen University105 enrolled1 locationNCT06903858
Recruiting
Phase 1Phase 2
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
Colorectal Cancer Stage IVMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)
Sun Yat-sen University28 enrolled1 locationNCT05426005
Recruiting
Phase 2
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Colorectal Cancer Metastatic
Sun Yat-sen University34 enrolled1 locationNCT06547203
Recruiting
Phase 2
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Advanced Rectal Cancer
Zhen-Hai Lu121 enrolled1 locationNCT05228431
Recruiting
Phase 2
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
Metastatic Colorectal Cancer，NED
Yanhong Deng52 enrolled1 locationNCT05360277
Recruiting
Not Applicable
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University240 enrolled1 locationNCT02649647
Recruiting
Not Applicable
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Rectal CancerLocally AdvancedMSS+1 more
Nanfang Hospital, Southern Medical University53 enrolled1 locationNCT05877573
Recruiting
Phase 3
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Rectal Cancer
Sun Yat-sen University776 enrolled2 locationsNCT03671252